|
Online Database of Chemicals from Around the World | Search | Submit | Advertise | |
Home >> Chemical Listing >> Vintafolide>> Market Analysis Reports |
Market Analysis Reports of Vintafolide |
|
Endocyte Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... therapeutic targeting PSMA; Vintafolide (Folate DAVLBH), SMDC, vintafolide, targets the folate receptor ... Global Pharmaceutical and Biotechnology Outlook 2014: Rising Stars Innovations have contributed to the availability of a range of new treatments for diseases resulting in improvement in the length and quality of life and reduced disease burden for individuals and society. However, the need for innovative therapies for ... Small Molecule Cancer Drug Clinical Pipeline Insight Please note: extra shipping charges are applied when purchasing Hard Copy License depending on the location. Oncologists are continuously looking for better therapeutic options to effectively cure and prevent different types of malignancies. Conventionally ... Global Ovarian Cancer Treatment Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023 ... to treat ovarian cancer. For instance, Vintafolide an investigational targeted cancer therapeutic currently ... ENDOCYTE - Small and Powerful Targeted Therapy! ... in US + royalty payment on ex. US to its key drug Vintafolide. ECYT expects a response to the 120 ... ASCO ‘13 - Promise of Novel Targets/Technologies to Unfold At ASCO 2013 ... , PhI), REGN421 (SAR153192, PhI); Endocyte’s Vintafolide (SMDCs, PhII); Halozyme’s PEGPH20 (PhI ... |